Professur für CAR-T-Zell-Therapie

Mechanistic Characterization of Tafasitamab-Mediated Antibody-Dependent Cellular Phagocytosis Alone or in Combination with Lenalidomide (2019) Mougiakakos D, Völkl S, Bach C, Stoll A, Bitterer K, Beier F, Endell J, et al. Conference contribution Microenvironmental Triggers Induce a Chemoresistant, Differentiated Subset of S100A8/A9(high) AML Cells Via the Jak/STAT3 Signaling Axis (2019) Böttcher M, Panagiotidis K, Mentz K, Völkl S, Bruns H, Slany R, Mackensen A, Mougiakakos D Conference contribution The Induction of a Permissive Environment to Promote T Cell Immune Evasion in Acute Myeloid Leukemia: The Metabolic Perspective (2019) Mougiakakos D Journal article, Review article Specific inhibition of PRMT5 suppresses human CD8+T cells by upregulation of p53 and impairment of the AKT pathway similar to the tumor metabolite MTA (2019) Strobl C, Schaffer S, Völkl S, Haug T, Peter K, Böttcher M, Mougiakakos D, et al. Conference contribution, Abstract of a poster PGAM5 acts as a key mediator of lung fibrosis by disrupting mitochondrial homeostasis (2019) Ganzleben I, He GW, Günther C, Prigge ES, Richter K, Rieker R, Mougiakakos D, et al. Conference contribution Mitochondrial metabolism influences plasma cell differentiation (2019) Urbanczyk S, Baris O, Reimer D, Steinmetz T, Mougiakakos D, Wiesner R, Mielenz D Conference contribution Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity (2019) Haug T, Aigner M, Peuser MM, Strobl C, Hildner K, Mougiakakos D, Bruns H, et al. Journal article Bone marrow stroma cells promote a S100A8/A9high subset of chemoresistant AML blasts with distinct metabolic features in a Jak/STAT-dependent manner (2019) Böttcher M, Panagiotidis K, Mentz K, Bruns H, Mackensen A, Mougiakakos D, Völkl S Conference contribution Monitoring of the immunometabolic profile of reconstituting leukocytes upon autologous peripheral blood stem cell transplantation (2019) Richter S, Jacobs B, Böttcher M, Stoll A, Böttcher-Loschinski R, Mackensen A, Mougiakakos D Conference contribution The oncometabolite 5 '-methylthioadenosine (MTA) blocks NK cell functions early after activation (2019) Jacobs B, Schlögl S, Mougiakakos D, Mackensen A, Aigner M, Völkl S Conference contribution